This is a Validated Antibody Database (VAD) review about human SH3BP2, based on 2 published articles (read how Labome selects the articles), using SH3BP2 antibody in all methods. It is aimed to help Labome visitors find the most suited SH3BP2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
SH3BP2 synonym: 3BP-2; 3BP2; CRBM; CRPM; RES4-23; SH3 domain-binding protein 2; Abl-SH3 binding protein 2; TNFAIP3 interacting protein 2

Knockout validation
Abnova
mouse monoclonal (1E9)
  • western blot knockout validation; mouse; loading ...; fig 5d
  • immunoprecipitation; mouse; loading ...; fig 1d
Abnova SH3BP2 antibody (Abnova, H00006452-M01) was used in western blot knockout validation on mouse samples (fig 5d) and in immunoprecipitation on mouse samples (fig 1d). J Clin Invest (2017) ncbi
Abnova
mouse monoclonal (1E9)
  • western blot; mouse; loading ...; fig 2a
Abnova SH3BP2 antibody (Abcam, H00006452-M01) was used in western blot on mouse samples (fig 2a). Bone (2018) ncbi
mouse monoclonal (1E9)
  • western blot knockout validation; mouse; loading ...; fig 5d
  • immunoprecipitation; mouse; loading ...; fig 1d
Abnova SH3BP2 antibody (Abnova, H00006452-M01) was used in western blot knockout validation on mouse samples (fig 5d) and in immunoprecipitation on mouse samples (fig 1d). J Clin Invest (2017) ncbi
Articles Reviewed
  1. Fujita S, Mukai T, Mito T, Kodama S, Nagasu A, Kittaka M, et al. Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastogenesis. Bone. 2018;106:156-166 pubmed publisher
  2. Matsumoto Y, LaRose J, Kent O, Lim M, Changoor A, Zhang L, et al. RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146. J Clin Invest. 2017;127:1303-1315 pubmed publisher